View
7
Download
0
Category
Preview:
Citation preview
THE USE OF BIOACTIVE STENT HELIFLEX
ON PATIENTS WITH ATHEROSCLEROTIC
LESIONS OF SUPERFICIAL FEMORAL
ARTERY: THE BEGINNING OF THE STUDY
A.OLESCHUK , M. GENERALOV, D. MAYSTRENKO, A. IVANOV, A.KHMELNITSKIY
FSBI «RUSSIAN RESEARCH CENTER OF RADIOLOGY AND SURDICAL TEHNOLOGIES» OF
MINISTRY OF HELTHCARE OF THE RUSSIAN FEDERATION, DEPARTMENT OF VASCULAR
SURGERY
St. Petersburg, Russia
2017
Disclosure
I do not have any potential conflict of interest
OBJECTIVE
To evaluate the results of the use of stents with
bioactive coating based in the treatment of
patients with atherosclerotic lesions of the
superficial femoral artery (SFA)
MATERIAL AND METHODS
Between January 2014 to December 2015
25 patient : 16 men and 9 women
Average age 61,3 ± 9,2 years
Classifying TASC II :
Type A - 9 (36 %)
Type B – 7 (28 %)
Type C – 9 (36 %)
MATERIAL AND METHODSclinical characteristics of the patients
MATERIAL AND METHODS Characteristics of the arterial bed of the lower limbs *
*according to CT and/or x-ray contrast angiography
MATERIAL AND METHODS Characteristics of the arterial bed of the lower limbs *
*according to CT and/or x-ray contrast angiography
MATERIAL AND METHODS
To determine the levels of blood nitric oxide used immunosorbent method
Assessment of the patency of the design was carried out according to the
ultrasonic duplex scanning is carried out in terms 30 days, 6 and 12 months
BIOACTIVE STENT HELIFLEX
(HexacatH, France)
Clinical outcome of registries and trials employing bioactive stents in coronary artery
EVIDENCE Registry
Mosseri et al
Pori Registry
TIBET Registry
TITAX AMI Trial
Bio Active Stent demonstrating reduced neointimal
proliferation
Bare Metal Stent (Control) showing neointimal proliferation.
BASE-ACS trial
BIOACTIVE STENT HELIFLEX
(HexacatH, France)
Stents diameter 6 to 8 mm
A length from 50 to 200 mm
ANGIOGRAHPY OF A PATIENT WITH DAMAGE
SFA
No-marker of endotelium disfunctionN=24mmol\l
RESULTS
Procedure success rate was 100 %
Levels of NO : preoperative average was 18,9 ± 2,3 mmol/l, after the
operation 28,9 ± 4,1 mmol/l
RESULTS
CONCLUSION
The use of stents with a bioactive coating based on titanium
oxynitride increases the level of NO in blood that can help to
prolong the period of function of endovascular construction.
The first data on the primary patency of stents of this type are
expected to improve long-term results of treatment of patient
with atherosclerotic lesions of the SFA.
THANK YOU!
THE USE OF BIOACTIVE STENT HELIFLEX
ON PATIENTS WITH ATHEROSCLEROTIC
LESIONS OF SUPERFICIAL FEMORAL
ARTERY: THE BEGINNING OF THE STUDY
A.OLESCHUK , M. GENERALOV, D. MAYSTRENKO, A. IVANOV, A.KHMELNITSKIY
FSBI «RUSSIAN RESEARCH CENTER OF RADIOLOGY AND SURDICAL TEHNOLOGIES» OF
MINISTRY OF HELTHCARE OF THE RUSSIAN FEDERATION, DEPARTMENT OF VASCULAR
SURGERY
St. Petersburg, Russia
2017
Recommended